SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-035948
Filing Date
2024-03-25
Accepted
2024-03-25 16:30:13
Documents
13
Period of Report
2024-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-20240325.htm   iXBRL 8-K 41432
2 EX-99.1 stro-ex99_1.htm EX-99.1 186890
3 GRAPHIC img217863751_0.jpg GRAPHIC 3348
  Complete submission text file 0000950170-24-035948.txt   357391

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240325.xsd EX-101.SCH 25176
16 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240325_htm.xml XML 4526
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 24779578
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)